Correlation between Skp2 expression and nodal metastasis in stage I and II oral squamous cell carcinomas.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Oral Diseases

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1601-0825.2010.01713.xPMID 20659261
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer cell cycle

  2012cited by this paper
• Prognostic importance of site in squamous cell carcinoma of the buccal mucosa.

  2009cited by this paper
• Current concepts in management of oral cancer--surgery.

  2009cited by this paper
• Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: prognostic implications.

  2008cited by this paper
• Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer

  2008cited by this paper
• Does Tumor Depth Affect Nodal Upstaging in Squamous Cell Carcinoma of the Head and Neck?

  2008cited by this paper
• Disease mechanism and biomarkers of oral squamous cell carcinoma

  2006cited by this paper
• Clinicopathological parameters and outcome of 245 patients operated for oral squamous cell carcinoma.

  2006influential reference
• Squamous cell carcinoma of the buccal mucosa: An aggressive cancer requiring multimodality treatment

  2006cited by this paper
• Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: A review of the literature

  2005cited by this paper
• Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma.

  2005cited by this paper
• Down-regulation of S-phase kinase associated protein 2 (Skp2) induces apoptosis in oral cancer cells.

  2005influential reference
• High expression of S-phase kinase-associated protein 2 (Skp2) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.

  2005influential reference
• Squamous cell carcinoma of the buccal mucosa: One institution's experience with 119 previously untreated patients

  2003cited by this paper
• Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.

  2003cited by this paper
• Deregulated degradation of the cdk inhibitor p27 and malignant transformation.

  2003cited by this paper
• Tumor thickness influences prognosis of T1 and T2 oral cavity cancer—but what thickness?

  2003cited by this paper
• Tumour thickness predicts cervical nodal metastases and survival in early oral tongue cancer.

  2003cited by this paper
• Skp2 and Jab1 Expression Are Associated with Inverse Expression of p27KIP1 and Poor Prognosis in Oral Squamous Cell Carcinomas

  2003cited by this paper
• Prognostic factors of clinically stage I and II oral tongue carcinoma—A comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, martinez‐gimeno score, and pathologic features

  2002cited by this paper
• Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.

  2002cited by this paper
• Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity.

  2002cited by this paper
• Skp2 is oncogenic and overexpressed in human cancers

  2001influential reference
• High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.

  2001cited by this paper
• Inverse relation between levels of p27Kip1 and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas

  2001cited by this paper
• Role of the F-box protein Skp2 in lymphomagenesis

  2001cited by this paper
• Early stage carcinoma of oral tongue: prognostic factors for local control and survival.

  2000cited by this paper
• Reduced expression of p27(Kip1) correlates with an early stage of cancer invasion in oral squamous cell carcinoma.

  2000cited by this paper
• Reduced expression of p27Kip1 correlates with an early stage of cancer invasion in oral squamous cell carcinoma

  2000cited by this paper
• Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma.

  2000cited by this paper
• Regulation of the Cdk inhibitor p27 and its deregulation in cancer

  2000cited by this paper
• p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells

  1999cited by this paper
• Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection.

  1999cited by this paper
• Cell cycle proteins and the development of oral squamous cell carcinoma.

  1999cited by this paper
• p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27.

  1999cited by this paper
• SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

  1999cited by this paper
• Expression of p27 is associated with Bax expression and spontaneous apoptosis in oral and oropharyngeal carcinoma

  1999cited by this paper
• Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma

  1999cited by this paper
• Reduced expression of cyclin‐dependent kinase inhibitor p27Kip1 is an indicator of malignant behavior in oral squamous cell carcinoma

  1998influential reference
• Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity.

  1998cited by this paper
• Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

  1997cited by this paper
• High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers.

  1997cited by this paper
• Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas

  1997cited by this paper
• Impact of the cyclin–dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents

  1996cited by this paper
• Cancer Cell Cycles

  1996cited by this paper
• Prediction of cervical lymph node metastasis in squamous cell carcinoma of the tongue/floor of mouth

  1995cited by this paper
• Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.

  1995cited by this paper
• Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: prognostic implications.

  1994cited by this paper
• p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

  1994cited by this paper
• Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.

  1994cited by this paper
• Dysplasia, in situ carcinoma, and progression to invasive squamous cell carcinoma of the upper aerodigestive tract.

  1989cited by this paper
• Dysplasia, in situ carcinoma, and progression to invasive squamous cell carcinoma of the upper aerodigestive tract.

  1989cited by this paper
• Oral pathology: Clinical-pathologic correlations

  1989cited by this paper
• Many gene changes found in cancer.

  1989cited by this paper
• Relation of thickness of floor of mouth stage I and II cancers to regional metastasis.

  1986cited by this paper

• E3 ligase Skp2-mediated stabilization of survivin contributes to radioresistance

  2025cites this paper
• The Skp2 Pathway: A Critical Target for Cancer Therapy.

  2020cites this paper
• Targeting SCF E3 Ligases for Cancer Therapies.

  2020cites this paper
• Ubiquitin, SUMO, and Nedd8 as Therapeutic Targets in Cancer.

  2020cites this paper
• E3 ubiquitin ligases in cancer and implications for therapies

  2017cites this paper
• Involvement of F-BOX proteins in progression and development of human malignancies.

  2016cites this paper
• DNA Copy Number Aberrations, and Human Papillomavirus Status in Penile Carcinoma. Clinico-Pathological Correlations and Potential Driver Genes

  2016cites this paper
• Associations and prognostic significance of p27Kip1, Jab1 and Skp2 in non-Hodgkin lymphoma

  2016cites this paper
• New insights into the mechanism of F-box proteins in colorectal cancer (Review).

  2015cites this paper
• E3 ubiquitin ligase Skp2 as an attractive target in cancer therapy.

  2015cites this paper
• E 3 ubiquitin ligase Skp 2 as an attractive target in cancer therapy

  2014cites this paper
• Acquisition of epithelial–mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells

  2014cites this paper
• Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo

  2013cites this paper
• Skp2: a novel potential therapeutic target for prostate cancer.

  2012cites this paper
• Skp2 is a Promising Therapeutic Target in Breast Cancer

  2011influential citation
• Cytoplasmic Skp2 Expression Is Increased in Human Melanoma and Correlated with Patient Survival

  2011cites this paper